Treatment of cancer cells derived from TBNC with high concentration of 17β‐estradiol (E2) induce reduction in MALAT1 mRNA expression by post‐transcriptional degradation,39 which indicates targeting the expression of MALAT1 in TNBC could be useful option for therapy development. This evidence concerns the gene MALAT1 and cancer.